Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | GLA | P06280 | 1/20 | 0.73 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.63 |
| ▸ | ST6GAL1 | P15907 | 9/20 | 0.59 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.56 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citicoline SCHEMBL31554836 | 1.00 | TSHR (0.73) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL50799 | 1.00 | TSHR (0.73) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL31413926 | 1.00 | TSHR (0.73) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL19347200 | 0.99 | TSHR (0.72) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL21906414 | 0.98 | TSHR (0.70) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL25411862 | 0.97 | TSHR (0.76) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL4311534 | 0.97 | TSHR (0.76) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL667104 | 0.93 | TSHR (0.84) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL14235352 | 0.93 | P2RY2 (0.70) | TSHRGLAP2RY2ST6GAL1P2RY6 | |
| Citicoline SCHEMBL13933086 | 0.93 | P2RY2 (0.70) | TSHRGLAP2RY2ST6GAL1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2607 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028930-A | Recovery of TIM4 in liver macrophages for the treatment of nonalcoholic steatohepatitis (NASH) | 纽约市哥伦比亚大学理事会 | 2026-05-12 | — | — | CN | claimed |
| US-20250376690-A1 | RECOMBINANT ENGINEERED STRAIN FOR DE NOVO SYNTHESIS OF CDP-CHOLINE USING GLUCOSE AS SUBSTRATE AND ITS PREPARATION METHOD AND APPLICATION | SHANDONG JINCHENG BIO PHARMACEUTICAL CO LTD (CN) | 2025-12-11 | — | — | US | claimed |
| CN-120189509-A | Novel target for treating metabolic-related fatty liver disease, regulatory molecule and application thereof | 上海交通大学医学院 | 2025-06-24 | — | — | CN | claimed |
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| US-20250170246-A1 | CDP-CHOLINE A HOST-DIRECTED THERAPEUTIC FOR DISEASE CAUSED BY SARS COV-2 INFECTION | OHIO STATE INNOVATION FOUNDATION | 2025-05-29 | — | — | US | claimed |
| WO-2025101437-A1 | MICROALGAE COMPOSITIONS AND METHODS FOR TREATING DISEASE | PHYCOIL BIOTECHNOLOGY INTERNATIONAL, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| WO-2025040605-A1 | OPHTHALMOLOGICAL COMPOSITION CONTAINING AT LEAST ONE NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR FOR TOPICAL ADMINISTRATION TO THE EYE FOR PREVENTING OR TREATING INFLAMMATION OF THE EYE | URSAPHARM ARZNEIMITTEL GMBH (DE) | 2025-02-27 | — | — | WO | claimed |
| US-20250043255-A1 | RECOMBINANT MICROORGANISM USED FOR PRODUCING CDP-CHOLINE, AND METHOD FOR PRODUCING CDP-CHOLINE USING SAID RECOMBINANT MICROORGANISM | KYOWA HAKKO BIO CO., LTD. (JP) | 2025-02-06 | — | — | US | claimed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | claimed |
| WO-2024263144-A1 | USE OF CHOLINE COMPRISING NUTRITIONAL SUPPLEMENTS WITH ANALGESIC EFFECTS IN PAIN CAUSED BY FIBROMYALGIA SYNDROME | DOKUZ EYLÜL ÜNİVERSİTESİ REKTÖRLÜĞÜ (TR) | 2024-12-26 | — | — | WO | claimed |
| US-4624852-A | TRYPTOPHANS AND CHOLINE OR DERIVATIVE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1986-11-25 | — | — | US | claimed |
| EP-0188647-A1 | Acylated derivatives of cytidine-diphosphate-choline, process for their preparation and their therapeutic use | NEOPHARMED S.p.A. (IT) | 1986-07-30 | — | — | EP | claimed |
| EP-0084169-B1 | METHOD FOR THE ORAL ADMINISTRATION OF SUBSTANCES IN THE FORM OF LIPOSOMES, AND RELATIVE PHARMACEUTICAL COMPOSITIONS | AUSONIA FARMACEUTICI S.r.l. (IT) | 1985-09-04 | — | — | EP | claimed |
| EP-0125900-A1 | A pharmaceutical composition for use in treating neurological disease or aging | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1984-11-21 | — | — | EP | claimed |
| EP-0084169-A1 | Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions | AUSONIA FARMACEUTICI S.r.l. (IT) | 1983-07-27 | — | — | EP | claimed |
| US-4386078-A | CYTIDINE DIPHOSPHOETHANOLAMINES AND CYTIDINEDIPHOSPHOCHOLINE; STROKE, CARDIOVASCULAR DISEASE, INJURIES | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1983-05-31 | — | — | US | claimed |
| US-4386077-A | TREATMENT OF CONSCIOUSNESS IMPAIRMENT | MADE ITALIANA S.R.L (IT) | 1983-05-31 | — | — | US | claimed |
| EP-0001197-B1 | COUPLING PRODUCTS OF CYTIDINE-DIPHOSPHOCHOLINE AND AMINO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL AND ANALYTICAL APPLICATION | Etablissement public dit: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1981-11-04 | — | — | EP | claimed |
| US-4203893-A | LYSINE RESIDUES OF PROTEINS, AMINOPOLYSACCHARIDES, SYNTHETIC PEPTIDES AND BACTERIASL BODIES | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1980-05-20 | — | — | US | claimed |
| EP-0001197-A2 | Coupling products of cytidine-diphosphocholine and amino compounds, process for their preparation and their pharmaceutical and analytical application | Etablissement public dit: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1979-03-21 | — | — | EP | claimed |